Source: New York Post
Another California company is pulling up stakes, with a $7 billion biotech firm moving its headquarters out of Irvine. CG Oncology, a Nasdaq-traded company focused on developing treatments for bladder cancer, has relocated its corporate headquarters to Dallas. The move took effect earlier this year, according to Sarah Connors, the company’s vice president of communications and patient advocacy.
Go to Source
Related News